Deciphera Pharmaceuticals INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$2.7Mgeneral payments (2019-2025)
$16Kresearch payments (2019-2025)
5,331clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Edward Benz | Boston, MA | Hematology (Internal Medicine) | $746,998.86 |
| Mark Agulnik | Los Angeles, CA | Medical Oncology | $85,397.86 |
| Seth Pollack | Chicago, IL | Hematology & Oncology | $57,253.08 |
| Adam Burgoyne | San Diego, CA | Hematology & Oncology | $50,319.51 |
| John Charlson | Milwaukee, WI | Hematology & Oncology | $48,068.55 |
| Arlene Ortega | San Diego, CA | Nurse Practitioner | $47,362.60 |
| Arun Singh | Santa Monica, CA | Hematology & Oncology | $42,366.57 |
| Ciara Kelly | New York, NY | Medical Oncology | $38,993.43 |
| William Tap | New York, NY | Hematology & Oncology | $35,004.89 |
| Dale Shepard | Cleveland, OH | Hematology & Oncology | $34,522.44 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.